Neuphoria Therapeutics Inc. (NEUP) FY2026 Annual P&L / Income Statement

Neuphoria Therapeutics Inc. (NEUP) FY2026 Annual P&L / Income Statement

Income statement for 2025-07-01 through 2026-06-30. Consolidated revenue, costs and expenses.

Total revenue

1,174,165 US dollars

Total operating expenses

17,625,231 US dollars

Loss from operations

negative 16,451,066 US dollars

Total other income

2,859,962 US dollars

Loss before income taxes

negative 13,591,104 US dollars

Income tax benefit

negative 139,173 US dollars

Net loss

negative 13,451,931 US dollars

Total operating expenses

17,625,231 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.